isradipine and cyclosporine

isradipine has been researched along with cyclosporine in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.17)18.7374
1990's14 (58.33)18.2507
2000's4 (16.67)29.6817
2010's5 (20.83)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Berg, KJ; Endresen, L; Fauchald, P; Hartmann, A; Holdaas, H; Pran, T; Solbu, D1
Martinez, F; Pirson, Y; van Ypersele de Strihou, C; Wallemacq, P1
Berg, KJ; Bergan, S; Endresen, L; Holdaas, H; Pran, T; Sinding-Larsen, B1
Clothier, N; Dawidson, I; Diller, K; Rooth, P1
Carozzi, S; Fontana, I; Nasini, MG; Nocera, A; Pietrucci, A; Valente, U1
Dieperink, H; Hansen, HV; Kemp, E; Kemp, M; Leyssac, PP; Starklint, H1
Ijzermans, JN; Schalekamp, MA; van den Dorpel, MA; Weimar, W; Zietse, R1
Fetkovska, N; Oravcova, J; Sojkova, D; Trnovec, T1
Besarab, A; Burke, JF; Francos, GF; McCrea, JB; Michael, HJ1
Ader, JL; Durand, D; Lloveras, JJ; Rostaing, L; Suc, JM; Tack, I; Tran-Van, T1
Bursztyn, M; Nagler, A; Or, R; Zelig, O1
Ahmed, K; Burke, JF; Michael, B1
Akkaya, V; Ark, E; Ecder, T; Sever, MS; Türk, S; Türkmen, A; Yildiz, A1
Chan, L; Jacob, LP; Malhotra, D; Shapiro, JI1
Bruijn, JA; de Fijter, JW; Hoitsma, AJ; Mulder, PG; Tegzess, AM; van Hooff, JP; van Riemsdijk, IC; Weimar, W1
Ijzermans, JN; van den Dorpel, MA; Weimar, W; Zietse, R1

Reviews

1 review(s) available for isradipine and cyclosporine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

8 trial(s) available for isradipine and cyclosporine

ArticleYear
Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.
    Therapeutic drug monitoring, 1991, Volume: 13, Issue:6

    Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cyclosporine; Dihydropyridines; Drug Administration Schedule; Female; Humans; Isradipine; Kidney Transplantation; Male; Middle Aged

1991
Immunosuppressive effects of different calcium channel blockers in human kidney allografts.
    Transplantation proceedings, 1995, Volume: 27, Issue:1

    Topics: Calcium; Calcium Channel Blockers; Cyclosporine; Cytokines; Diltiazem; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Isradipine; Kidney Transplantation; Lymphocytes; Prednisolone; Transplantation, Homologous; Verapamil

1995
Effect of isradipine on cyclosporin A-related hypertension.
    Blood pressure. Supplement, 1994, Volume: 1

    Topics: Blood Pressure; Cyclosporine; Double-Blind Method; Humans; Hypertension; Isradipine; Kidney Transplantation; Postoperative Care; Prospective Studies

1994
Renal functional reserve in calcium channel blocker-treated hypertensive recipients of kidney transplant.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10 Suppl 6

    Topics: Adult; Amino Acids; Calcium Channel Blockers; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Isradipine; Kidney Transplantation; Male; Middle Aged; Nifedipine; Nitrendipine; Renal Plasma Flow; Retrospective Studies

1995
Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study.
    Transplantation, 1997, Apr-15, Volume: 63, Issue:7

    Topics: Adult; Antihypertensive Agents; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Hypertension; Immunosuppressive Agents; Isradipine; Male; Pilot Projects; Transplantation, Homologous

1997
Interaction between cyclosporine A and verapamil, felodipine, and isradipine.
    Nephron, 1999, Volume: 81, Issue:1

    Topics: Adult; Calcium Channel Blockers; Cyclosporine; Drug Interactions; Felodipine; Female; Humans; Immunosuppressive Agents; Isradipine; Kidney Transplantation; Male; Verapamil

1999
Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study.
    Transplantation, 2000, Jul-15, Volume: 70, Issue:1

    Topics: Adult; Aged; Calcium Channel Blockers; Cyclosporine; Double-Blind Method; Female; Humans; Isradipine; Kidney; Kidney Transplantation; Male; Middle Aged; Thrombosis

2000
Prophylactic isradipine treatment after kidney transplantation: a prospective double-blind placebo-controlled randomized trial.
    Transplant international : official journal of the European Society for Organ Transplantation, 1994, Volume: 7 Suppl 1

    Topics: Adult; Antilymphocyte Serum; Blood Pressure; Calcium Channel Blockers; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Histocompatibility Testing; Humans; Hydrocortisone; Immunosuppressive Agents; Isradipine; Kidney; Kidney Transplantation; Male; Middle Aged; Placebos; Postoperative Complications; Tissue Donors

1994

Other Studies

15 other study(ies) available for isradipine and cyclosporine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
    Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10

    Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1991, Volume: 6, Issue:10

    Topics: Adult; Aged; Body Water; Calcium Channel Blockers; Cyclosporine; Dihydropyridines; Electrolytes; Female; Hemodynamics; Humans; Isradipine; Kidney; Kidney Transplantation; Lithium; Male; Middle Aged

1991
No clinically significant interaction between ciclosporin and isradipine.
    Nephron, 1991, Volume: 59, Issue:4

    Topics: Calcium Channel Blockers; Cyclosporine; Dihydropyridines; Drug Interactions; Humans; Hypertension, Renal; Isradipine; Kidney Transplantation

1991
In vivo fluorescence microscopy reveals cyclosporine G to be less nephrotoxic than cyclosporine A.
    Transplantation proceedings, 1988, Volume: 20, Issue:2 Suppl 2

    Topics: Animals; Calcium Channel Blockers; Cyclosporine; Cyclosporins; Female; Isradipine; Kidney; Male; Mice; Microcirculation; Microscopy, Fluorescence; Oxadiazoles; Regional Blood Flow

1988
Long-term cyclosporin A nephrotoxicity in the rat. Evaluation of a morphological scoring system and of co-treatment with isradipine.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1994, Volume: 102, Issue:5

    Topics: Animals; Cyclosporine; Isradipine; Kidney Diseases; Male; Prospective Studies; Rats; Rats, Sprague-Dawley; Time Factors

1994
Factors influencing isradipine and amlodipine binding to human plasma lipoproteins.
    Blood pressure. Supplement, 1994, Volume: 1

    Topics: Amlodipine; Blood; Cyclosporine; Humans; Isradipine; Lipoproteins

1994
The beneficial effects of isradipine on renal hemodynamics in cyclosporine-treated renal transplant recipients.
    Transplantation, 1993, Volume: 55, Issue:3

    Topics: Adult; Creatinine; Cyclosporine; Diastole; Glomerular Filtration Rate; Hemodynamics; Humans; Isradipine; Kidney; Kidney Transplantation; Middle Aged; Regional Blood Flow; Renal Circulation; Vascular Resistance

1993
Effects of isradipine on renal hemodynamics in renal transplant patients treated with cyclosporine.
    Clinical nephrology, 1997, Volume: 48, Issue:5

    Topics: Adolescent; Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cyclosporine; Female; Humans; Immunosuppression Therapy; Isradipine; Kidney Transplantation; Male; Middle Aged; Renal Circulation

1997
Absence of a dose-response of cyclosporine levels to clinically used doses of diltiazem and verapamil.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1999, Volume: 33, Issue:2

    Topics: Administration, Oral; Calcium Channel Blockers; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Isradipine; Medical Records; Nifedipine; Radioimmunoassay; Retrospective Studies; Verapamil

1999